Literature DB >> 6975284

Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children.

P H Stern, A B Taylor, N H Bell, S Epstein.   

Abstract

The effects of vitamin D, 2.5 mg (100,000 U)/d for 4 d, on serum calcium, serum 25-hydroxyvitamin D (25-OHD) and serum 1 alpha, 25-dihydroxyvitamin D (1 alpha, 25(OH)2D) were compared in 24 normal adults and 12 normal children. The daily dose of vitamin D was 1,500 U/kg body wt in children weighing less than 45 kg. Vitamin D increased mean serum calcium from 9.5 +/- 0.1 to 9.8 +/- 0.1 mg/dl (P less than 0.05), increased mean serum phosphorus from 4.6 +/- 0.1 to 5.0 +/- 0.1 mg/dl (P less than 0.01), increased mean serum 25-OHD from 25 +/- 3 to 34 +/- 4 ng/ml (P less than 0.001), and increased mean serum 1 alpha, 25(OH)2D from 34 +/- 3 to 42 +/- 4 pg/ml (P less than 0.02) in children. In contrast, vitamin D increased mean serum 25-OHD from 18 +/- 2 to 39 +/- 6 ng/ml (P less than 0.001) and did not change mean serum calcium (9.4 +/- 0.1 vs. 9.5 +/- 0.1 mg/dl), mean serum phosphorus (4.0 +/- 0.1 vs. 4.1 +/- 0.1 mg/dl), or mean serum 1 alpha, 25(OH)2D (31 +/- 2 vs. 29 +/- 3 pg/ml) in adults. Mean serum 1 alpha, 25(OH)2D was significantly higher after vitamin D in children than in adults (P less than 0.02). These results provide evidence that circulating 1 alpha, 25(OH)2D is not as tightly regulated in children as it is in adults. This difference in regulation could account in part for the higher values for serum 1 alpha, 25(OH)2D observed in children.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975284      PMCID: PMC370935          DOI: 10.1172/jci110386

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Circadian variation of integrated concentration of growth hormone in children and adults.

Authors:  L P Plotnick; R G Thompson; A Kowarski; L de Lacerda; C J Migeon; R M Blizzard
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

2.  1,25-Dihydroxyvitamin D3: mode of action in intestine and parathyroid glands, assay in humans and isolation of its glycoside from Solanum malacoxylon.

Authors:  M R Haussler; M R Hughes; T A McCain; J E Zerwekh; P F Brumbaugh; W Jubiz; R H Wasserman
Journal:  Calcif Tissue Res       Date:  1977-05

3.  A rapid assay for 25-OH-vitamin D3 without preparative chromatography.

Authors:  R E Belsey; H F DeLuca; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

4.  Increases in immunoreactive parathyroid hormone with age.

Authors:  P S Wiske; S Epstein; N H Bell; S F Queener; J Edmondson; C C Johnston
Journal:  N Engl J Med       Date:  1979-06-21       Impact factor: 91.245

5.  Direct microdetermination of serum calcium.

Authors:  E S Baginski; S S Marie; W L Clark; B Zak
Journal:  Clin Chim Acta       Date:  1973-06-14       Impact factor: 3.786

6.  Determination of serum calcium by means of orthocresolphthalein complexone.

Authors:  H V Connerty; A R Briggs
Journal:  Am J Clin Pathol       Date:  1966-03       Impact factor: 2.493

7.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

8.  Parathyroid function and vitamin D metabolism during human growth hormone replacement.

Authors:  J M Gertner; R L Horst; A E Broadus; H Rasmussen; M Genel
Journal:  J Clin Endocrinol Metab       Date:  1979-08       Impact factor: 5.958

9.  Effects of human growth hormone in man.

Authors:  P H HENNEMAN; A P FORBES; M MOLDAWER; E F DEMPSEY; E L CARROLL
Journal:  J Clin Invest       Date:  1960-08       Impact factor: 14.808

10.  Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.

Authors:  R W Chesney; R B Mazess; A J Hamstra; H F DeLuca; S O'Reagan
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

View more
  5 in total

Review 1.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

2.  Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism.

Authors:  S Epstein; P H Stern; N H Bell; I Dowdeswell; R T Turner
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

Review 3.  The Progress of the Prevention and Treatment of Vitamin D to Tuberculosis.

Authors:  Li Cai; Gaoming Wang; Peijun Zhang; Xinyi Hu; Hao Zhang; Fan Wang; Yeqing Tong
Journal:  Front Nutr       Date:  2022-05-17

Review 4.  Benefit-risk assessment of vitamin D supplementation.

Authors:  H A Bischoff-Ferrari; A Shao; B Dawson-Hughes; J Hathcock; E Giovannucci; W C Willett
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

5.  Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man.

Authors:  N H Bell; S Shaw; R T Turner
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.